Treatment with BTZ did not result in significantly higher levels of misfolded λ light chains in the ER of the myeloma cells as detected by α-FLAG IP before the occurrence of apoptosis (Figure 3B). The gene discussed is CASC3; the disease is plasma cell myeloma.